Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Drug Development Research
|
August 29, 2024
Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
October 25, 2023
Layered double hydroxide nanocarriers: potential delivery systems for mefenamic acid
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
May 7, 2026
Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
February 9, 2026
Antibody-drug conjugates for precision oncology in cholangiocarcinoma
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
February 9, 2026
O-glycosylation as a potential biomarker in Alzheimer's disease
Parteek Prasher, Mousmee Sharma
Drug Development Research
|
August 16, 2023
Hybridization of antimicrobial oxazolidinones with commercial drugs: A fight against the "superbugs"
Parteek Prasher, Mousmee Sharma
Medchemcomm
|
September 20, 2019
Tailored therapeutics based on 1,2,3-1<i>H</i>-triazoles: a mini review
Parteek Prasher, Mousmee Sharma
Future Medicinal Chemistry
|
August 6, 2020
<i>N</i>-acetylgalactosaminyltransferase: a potential target for colorectal adenocarcinoma
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
May 11, 2021
Nanotechnology-based self-sterilizing surfaces and their potential in combating COVID-19
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
November 3, 2021
Mucoadhesive nanoformulations and their potential for combating COVID-19
Parteek Prasher, Mousmee Sharma
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Drug Development Research
|
August 29, 2024
Starch-based "smart" nanomicelles: Potential delivery systems for doxorubicin
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
October 25, 2023
Layered double hydroxide nanocarriers: potential delivery systems for mefenamic acid
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
May 7, 2026
Polymorphism engineering of mefenamic acid for enhanced pharmacokinetic performance
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
February 9, 2026
Antibody-drug conjugates for precision oncology in cholangiocarcinoma
Parteek Prasher, Mousmee Sharma
EXCLI Journal
|
February 9, 2026
O-glycosylation as a potential biomarker in Alzheimer's disease
Parteek Prasher, Mousmee Sharma
Drug Development Research
|
August 16, 2023
Hybridization of antimicrobial oxazolidinones with commercial drugs: A fight against the "superbugs"
Parteek Prasher, Mousmee Sharma
Medchemcomm
|
September 20, 2019
Tailored therapeutics based on 1,2,3-1<i>H</i>-triazoles: a mini review
Parteek Prasher, Mousmee Sharma
Future Medicinal Chemistry
|
August 6, 2020
<i>N</i>-acetylgalactosaminyltransferase: a potential target for colorectal adenocarcinoma
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
May 11, 2021
Nanotechnology-based self-sterilizing surfaces and their potential in combating COVID-19
Parteek Prasher, Mousmee Sharma
Nanomedicine (London, England)
|
November 3, 2021
Mucoadhesive nanoformulations and their potential for combating COVID-19
Parteek Prasher, Mousmee Sharma
Page
of 7